As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's Discounted Cash Flow (DCF) valuation estimates its share price at $66.4. This suggests it may be undervalued by 189.3% compared to its current price of around $22.9, using a WACC of 4.8% and growth rates of 3.0%.
As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's Weighted Average Cost of Capital (WACC) is approximately 4.8%.
As of Feb 20, 2025, Fresenius Medical Care AG & Co. KGaA's Enterprise Value (EV) is approximately €47.6B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.